Senate grills pharma CEOs, who emerge from hearing on drug prices largely unscathed

For about three hours on Thursday, senators pressed the CEOs of Merck, Bristol Myers Squibb and Johnson & Johnson on why US drugs cost so much. And for those three hours, the CEOs largely parried lawmakers’ questions, sticking to their message of blaming PBMs and citing the high cost of…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks

Advertise With Biotech Networks